Wilson Sonsini Aids Wright Medical In $380M BioMimetic Deal

Law360, New York (November 19, 2012, 1:57 PM EST) -- Hip- and knee-implant maker Wright Medical Technology Inc. will combine with BioMimetic Therapeutics Inc., a biotechnology firm specializing in orthopedic and sports-medicine therapies, in a deal worth up to $380 million, the companies said Monday.

Under the transaction's terms, BioMimetic investors will first receive a $1.50 cash payment for each of their units in addition to 0.25 Wright Medical shares, valuing Franklin, Tenn.-based BioMimetic at about $190 million, or $6.47 per share, a 35 percent premium over Friday's close.

BioMimetic shareholders would get another $6.50 per...
To view the full article, register now.